|
|
Joining hands: Mr Malvinder Mohan Singh, CEO and Managing Director, Ranbaxy, and Mr Takashi Shoda, President and CEO, Daiichi Sankyo Co Ltd, at a press conference in the Capital on June 11, 2008.
Is sell-out the cure? (2008/06/27) New
The soft touch on hard decisions (2008/06/23) New
Ranbaxy promoters’ timely exit (2008/06/19) New
Ranbaxy sell-out — Indian entrepreneurs not come of age yet? (2008/06/18) New
Daiichi Sankyo’s open offer for Ranbaxy opens on August 8 (2008/06/17) New
Ranbaxy shares up on buzz of Pfizer interest (2008/06/14)
Winning formula (2008/06/13)
Ranbaxy buy may hit generic drugs supply (2008/06/13)
Why Ranbaxy Labs stock is falling? (2008/06/13)
Daiichi Sankyo to buy 51% in Ranbaxy at Rs 737/share (2008/06/12)
‘This sale is for strategic growth’ (2008/06/12)
‘We want to be number one player in Japan’ (2008/06/12)
Ranbaxy stake sale — When predator turned prey (2008/06/12)
Premium for Ranbaxy buy among the highest (2008/06/12)
Ranbaxy to serve Japanese generic ambitions (2008/06/12)
Daiichi Sankyo makes a big splash (2008/06/12)
Ranbaxy goes back to its Japanese roots (2008/06/12)
LIC will wait for Daiichi open offer (2008/06/12)
Ranbaxy: ‘Bought on rumour and sold on news’ (2008/06/12)
‘Opens Japan market for Jupiter Bio’ (2008/06/12)
Takeover takes industry by surprise (2008/06/12)
Ranbaxy: Milestones (2008/06/12)
Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line
|
|
